Selway Asset Management Has $4.72 Million Position in Amgen Inc. (AMGN)

Marco Green
October 12, 2017

(NASDAQ:AMGN) opened at 155.01 on Friday. Amgen has a 1-year low of $133.64 and a 1-year high of $191.10.

Amgen Inc. has a 50 day moving average of 182.35 and a 200 day moving average of 170.56.

Amgen Inc is a biotechnology company. The stock of Amgen, Inc. (NASDAQ:AMGN) on Sunday, August 27 with "Buy" rating. The stock now has a consensus rating of "Buy" and an average target price of $189.99. The stock of SAGE Therapeutics Inc (NASDAQ:SAGE) has "Sell" rating given on Tuesday, May 24 by Chardan Capital Markets. The firm earned "Overweight" rating on Saturday, August 29 by Piper Jaffray. The Average Volume of the company is 2.48 Million, while the Volume of the company in the last trading session was 1.67 Billion. On Friday, December 18 the stock rating was initiated by Atlantic Securities with "Overweight".

D L Carlson Investment Group Inc increased Abbvie Inc. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Eventide Asset Mgmt Limited Liability Co accumulated 81,000 shares or 0.4% of the stock. The stock rose 0.32% or $0.31 reaching $97.14 per share.

Amgen Inc. most recently reported earnings per share (EPS) of $3.27 for the June 2017 versus $2.84 in the same quarter a year ago, representing 15% growth. Abbvie Inc. now has $147.26 billion valuation. About 116,375 shares traded. McCormick & Company, Incorporated (NYSE:MKC) has risen 5.12% since October 10, 2016 and is uptrending. It has underperformed by 6.07% the S&P500. The stock price recently experienced a 5-day loss of -2.35% with 3.12 average true range (ATR). Noting its average daily volume at 6.72 million shares each day over the month, this signifies a pretty significant change over the norm. About 661,772 shares traded. It also upped Scansource Inc (NASDAQ:SCSC) stake by 12,501 shares and now owns 154,439 shares. (NASDAQ:AMGN) shares have been seen trading -1.60% away from the 20-day moving average. (AMGN)-5 analysts issued Buy for the stock, 5 analysts gave Outperform rating, 14 think it's a Hold, 0 issued Underperform, while 0 analyst gave a Sell rating. Therefore 100% are positive. The stock of Amgen, Inc. On Friday, September 29 the stock rating was maintained by Stifel Nicolaus with "Hold". The firm earned "Buy" rating on Thursday, September 3 by Leerink Swann. Hot Stocks Point (HSP) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. Vetr cut Amgen from a "hold" rating to a "sell" rating and set a $174.10 price objective for the a research note on Monday, March 13th. (NASDAQ:AMGN) rating on Tuesday, November 8. The rating was initiated by Citigroup on Thursday, February 25 with "Neutral". Jefferies maintained McCormick & Company, Incorporated (NYSE:MKC) rating on Thursday, June 22.

07/20/2017 - Amgen Inc. had its "outperform" rating reiterated by analysts at Cowen. Lake Street has "Buy" rating and $90 target.

On a similar note, analysts expect EPS of $3.07 in September 2017 quarter and $3.06 in December 2017 quarter, representing 1.66% and 5.88% growth, respectively. Its down 0.10, from 1.25 in 2017Q1. It dropped, as 72 investors sold AMGN shares while 463 reduced holdings. 138 funds opened positions while 500 raised stakes. Montgomery Mngmt owns 20,137 shares for 0.64% of their portfolio. Welch And Forbes Ltd Llc holds 42,130 shares or 0.2% of its portfolio. Baxter Bros has invested 0.19% of its portfolio in Amgen, Inc. Natl Asset Management Inc reported 26,774 shares stake. (NASDAQ:AMGN). Alta Mgmt Ltd Liability Company holds 3,096 shares or 0.04% of its portfolio. Oppenheimer Asset Mgmt stated it has 38,232 shares or 0.18% of all its holdings. Cadence Retail Bank Na stated it has 16,856 shares or 0.56% of all its holdings. Essex Invest Mgmt Co Ltd Co reported 31,660 shares. Current market cap is $136.59B and the stock has an EPS of $11.00. Aberdeen Asset Plc Uk reported 848,944 shares.

Short traders are more bearish on the company recently if you evaluate the rise in short interest. The Bailard Inc holds 312,312 shares with $21.53 million value, down from 322,855 last quarter. The insider Patton Cynthia M sold $451,164.

Amgen Inc.'s shares may have great momentum, but how has it been performing relative to the market? Following the transaction, the senior vice president now directly owns 24,214 shares in the company, valued at approximately $3,738,641.60.

Currently, the stock carries a price to earnings ratio of 135.77, a price to book ratio of 50.31, and a price to sales ratio of 23.16. The Company discovers, develops, manufactures and delivers various human therapeutics. The P/E Ratio for AMGN is 16.91. The Company operates in the human therapeutics segment. The stock volatility for the week was 1.75% while for the month was 1.56%.

FT reports, The 20 analysts offering 12 month price targets for Amgen, Inc. have a median target of 187.00, with a high estimate of 216.00 and a low estimate of 165.00. It also reduced Disney Walt Co (NYSE:DIS) stake by 3,050 shares and now owns 4,759 shares.

Other reports by Click Lancashire

Discuss This Article